United States 115th Congress Status: Passed House Bipartisan · 7 R · 1 D cosponsors

HR 5687 — SOUND Disposal and Packaging Act

Last action — Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 115th Congress. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Summary

Securing Opioids and Unused Narcotics with Deliberate Disposal and Packaging Act of 2018 or the SOUND Disposal and Packaging Act This bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Food and Drug Administration to require certain packaging and disposal technologies, controls, or measures to mitigate the risk of abuse or misuse of a drug or a class of drugs.

Bill Text

What changed in the latest version

6 added · 1 removed

Plain-language change summary

The text indicates that the version of H.R. 5687 referred to the Senate has been updated to reflect that it has been received, read twice, and referred to the Committee on Health, Education, Labor, and Pensions. Additionally, the previous designation of "Engrossed in House" has been removed. This change matters because it signifies the bill's progression to the Senate for further consideration.

→
Previous
Latest
5687 Engrossed in House (EH)] <DOC> 115th CONGRESS 2d Session H.
5687 Referred in Senate (RFS)] <DOC> 115th CONGRESS 2d Session H.
5687 _______________________________________________________________________ AN ACT To amend the Federal Food, Drug, and Cosmetic Act to require improved packaging and disposal methods with respect to certain drugs, and for other purposes.
5687 _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES June 20, 2018 Received;
read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ AN ACT To amend the Federal Food, Drug, and Cosmetic Act to require improved packaging and disposal methods with respect to certain drugs, and for other purposes.
Clerk.
KAREN L.
115th CONGRESS 2d Session H.
HAAS, Clerk.
R.
5687 _______________________________________________________________________ AN ACT To amend the Federal Food, Drug, and Cosmetic Act to require improved packaging and disposal methods with respect to certain drugs, and for other purposes.
⬇ Download PDF
View plain text versions (3)

How this bill changes current law

4 changes Share ↗

Compared against current U.S. Code AI-generated reading aid — verify against the official bill.

The bill introduces new requirements for packaging and disposal methods for certain drugs to mitigate the risk of misuse and abuse.

  • 21 U.S.C. 355

    SEC. 505-2. SAFETY-ENHANCING PACKAGING AND DISPOSAL FEATURES.

    This section establishes a new requirement for safety-enhancing packaging and disposal features for certain drugs.

  • 21 U.S.C. 351

    (k) If it is a drug approved under a covered application (as defined in section 505-2(e)), the holder of which does not meet the requirements of paragraphs (1) and (2) of subsection (b) of such section.

    This addition allows drugs that fail to meet new packaging and disposal requirements to be classified as adulterated.

  • 21 U.S.C. 355(j)(2)(A)

    by striking the period at the end and inserting ``; and``; → ``(ix) if the drug is or contains an opioid for which a listing in schedule II or III (on a temporary or permanent basis) is in effect under section 202 of the Controlled Substances Act, information to show that the applicant has proposed technologies, controls, or measures related to the packaging or disposal of the drug that provide protections comparable to those provided by the technologies, controls, or measures required for the applicable listed drug under section 505-2, if applicable.``

    This change requires additional information regarding opioid packaging and disposal measures in abbreviated new drug applications.

  • 21 U.S.C. 355(j)(4)

    by striking the period at the end and inserting ``; or``; → ``(L) if the drug is a drug described in paragraph (2)(A)(ix) and the applicant has not proposed technologies, controls, or measures related to the packaging or disposal of such drug that the Secretary determines provide protections comparable to those provided by the technologies, controls, or measures required for the applicable listed drug under section 505-2.``

    This change expands the grounds for refusing to approve an abbreviated new drug application if it does not meet packaging and disposal requirements for opioids.

Action History

  1. Introduced in House

  2. Introduced in House

  3. Referred to the House Committee on Energy and Commerce.

  4. Committee Consideration and Mark-up Session Held.

  5. Ordered to be Reported by Voice Vote.

  6. Mr. Walden moved to suspend the rules and pass the bill, as amended.

  7. Considered under suspension of the rules. (consideration: CR H5234-5237)

  8. DEBATE - The House proceeded with forty minutes of debate on H.R. 5687.

  9. At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

  10. Considered as unfinished business. (consideration: CR H5271-5272)

  11. Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 342 - 13 (Roll no. 269).(text: CR H5234-5235)

  12. On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 342 - 13 (Roll no. 269). (text: CR H5234-5235)

  13. Motion to reconsider laid on the table Agreed to without objection.

  14. Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 7 co-sponsors · 539 not signed on

Sponsors (1)

Co-sponsors (7)

Not signed on (539)

539 members have not signed on to this bill.

Show all 539 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

environment health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 5687 do?
Securing Opioids and Unused Narcotics with Deliberate Disposal and Packaging Act of 2018 or the SOUND Disposal and Packaging Act This bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Food and Drug Administration to require certain packaging and disposal technologies, controls, or measures to mitigate the risk of abuse or misuse of a drug or a class of drugs.
Who sponsors HR 5687?
HR 5687 is sponsored by Butterfield, G. K. (Democratic), Budd, Ted (Republican), Blackburn, Marsha (Republican), Poliquin, Bruce (Republican), Barr, Andy (Republican), Herrera Beutler, Jaime (Republican), Walden, Greg (Republican), and Hudson, Richard (Republican).
What is the current status of HR 5687?
This bill died with 115th Congress. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HR 5687?
Track HR 5687 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 5687

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 5687

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →